Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156429 · ClinicalTrials.gov registry record
Genetic Predictors of Outcome in HCM Patients
A clinical trial, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- 98
- Enrollment target
NCT00156429 is a clinical trial that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 98 participants.
The verdict
NCT00156429 was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- 98 participants
- Enrollment target
Study Summary
This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples are being examined in this cohort to determine whether certain to determine whether certain beta-AR polymorphisms as well as other common genetic polymorphisms are associated with different morphological features, such as LVH in patients with HCM and whether these polymorphisms influence the clinical course and outcome in patients with HCM. For that purpose, we will build a database with clinical information including serial echocardiographic measurements for patients with HCM that have regular follow up and test them for beta-AR polymorphisms as well as other common genetic polymorphisms and other known cardiac-related polymorphisms that can potentially contribute to the morphologic differences seen in patients with HCM.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2009-04-22 |
| Est. Completion | 2020-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156429
The ClinicalTrials.gov registry entry for NCT00156429 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00156429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00156429 about?
NCT00156429 is a clinical study titled "Genetic Predictors of Outcome in HCM Patients". This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples are being examined in this cohort to determine whether certain to determine whether certain beta-AR...
What is the current status of trial NCT00156429?
This trial is currently terminated. The enrollment target is 98 participants. The study started on 2009-04-22. Estimated completion is 2020-07-30.
Who is sponsoring clinical trial NCT00156429?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.